Journal of Animal and Veterinary Advances
Year:
2014
Volume:
13
Issue:
17
Page No.
1056 - 1060
References
Auluck, A., G. Hislop, C. Bajdik, C. Poh, L. Zhang and M. Rosin, 2010. Trends in oropharyngeal and oral cavity cancer incidence of Human Papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population. Cancer, 116: 2635-2644.
CrossRef | PubMed | Direct Link | Kim, L., T. King and M. Agulnik, 2010. Head and neck cancer: Changing epidemiology and public health implications. Oncology (Williston Park), 24: 915-919, 924.
PubMed | Direct Link | Laco, J., H. Vosmikova, V. Novakova, P. Celakovsky and H. Dolezalova
et al., 2011. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: A clinicopathological and molecular study of 46 cases. Virchows Arch., 458: 179-187.
CrossRef | PubMed | Direct Link | Machiels, J.P. and S. Schmitz, 2011. Molecular-targeted therapy of head and neck squamous cell carcinoma: Beyond cetuximab-based therapy. Curr. Opin. Oncol., 23: 241-248.
CrossRef | PubMed | Marur, S. and A.A. Forastiere, 2008. Head and neck cancer: Changing epidemiology, diagnosis and treatment. Mayo. Clin. Proc., 83: 489-501.
CrossRef | PubMed | Direct Link | Massarelli, E., D.D. Liu, J.J. Lee, A.K. El-Naggar and L. Lo Muzio
et al., 2005. Akt activation correlates with adverse outcome in tongue cancer. Cancer, 104: 2430-2436.
PubMed | Morgensztern, D. and H.L. McLeod, 2005. PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs, 16: 797-803.
PubMed | Nagata, Y., K.H. Lan, X. Zhou, M. Tan and F.J. Esteva
et al., 2004. PTEN activation contributes to tumor inhibition by trastuzumab and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell, 6: 117-127.
CrossRef | PubMed | Direct Link | Yu, Z., P.M. Weinberger, C. Sasaki, B.L. Egleston and W.F. Speier
et al., 2007. Phosphorylation of Akt (Ser
473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiol. Biomarkers Prev., 16: 553-558.
CrossRef | PubMed | Direct Link |